These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
706 related articles for article (PubMed ID: 17980020)
41. Clinical and mutational characteristics of oculocutaneous albinism type 7. Kruijt CC; de Wit GC; van Minderhout HM; Schalij-Delfos NE; van Genderen MM Sci Rep; 2024 Mar; 14(1):7572. PubMed ID: 38555393 [TBL] [Abstract][Full Text] [Related]
42. Ophthalmological Manifestations of Oculocutaneous and Ocular Albinism: Current Perspectives. Neveu MM; Padhy SK; Ramamurthy S; Takkar B; Jalali S; Cp D; Padhi TR; Robson AG Clin Ophthalmol; 2022; 16():1569-1587. PubMed ID: 35637898 [TBL] [Abstract][Full Text] [Related]
43. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa. Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493 [TBL] [Abstract][Full Text] [Related]
44. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739 [TBL] [Abstract][Full Text] [Related]
45. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663 [TBL] [Abstract][Full Text] [Related]
46. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing. Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374 [TBL] [Abstract][Full Text] [Related]
47. Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient. Rooryck C; Roudaut C; Robine E; Müsebeck J; Arveiler B Pigment Cell Res; 2006 Jun; 19(3):239-42. PubMed ID: 16704458 [TBL] [Abstract][Full Text] [Related]
48. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism. Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476 [TBL] [Abstract][Full Text] [Related]
49. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism. Kessel L; Kjer B; Lei U; Duno M; Grønskov K Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type. Hutton SM; Spritz RA J Invest Dermatol; 2008 Oct; 128(10):2442-50. PubMed ID: 18463683 [TBL] [Abstract][Full Text] [Related]
51. Delineating the genetic heterogeneity of OCA in Hungarian patients. Fábos B; Farkas K; Tóth L; Sulák A; Tripolszki K; Tihanyi M; Németh R; Vas K; Csoma Z; Kemény L; Széll M; Nagy N Eur J Med Res; 2017 Jun; 22(1):20. PubMed ID: 28629449 [TBL] [Abstract][Full Text] [Related]
53. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism. Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097 [TBL] [Abstract][Full Text] [Related]
54. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II. Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966 [TBL] [Abstract][Full Text] [Related]
55. Genetic Variability in Slovenian Cohort of Patients with Oculocutaneous Albinism. Hovnik T; Debeljak M; Tekavčič Pompe M; Bertok S; Battelino T; Stirn Kranjc B; Trebušak Podkrajšek K Acta Chim Slov; 2021 Sep; 68(3):683-692. PubMed ID: 34897530 [TBL] [Abstract][Full Text] [Related]
56. Electron microscopic DOPA reaction test for oculocutaneous albinism. Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771 [TBL] [Abstract][Full Text] [Related]
57. Genetic analysis of albinism caused by compound heterozygous mutations of the OCA2 gene in a Chinese family. Wang Y; Chang Y; Gao M; Zang W; Liu X Hereditas; 2024 Feb; 161(1):8. PubMed ID: 38317267 [TBL] [Abstract][Full Text] [Related]
58. [An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals]. Sanabria D; Groot H; Guzmán J; Lattig MC Biomedica; 2012 Jun; 32(2):269-76. PubMed ID: 23242301 [TBL] [Abstract][Full Text] [Related]
59. TYPES OF ALBINISM IN THE BLACK SOUTHERN AFRICA POPULATION. Kromberg JG; Bothwell J; Kidson SH; Manga P; Kerr R; Jenkins T East Afr Med J; 2012 Jan; 89(1):20-7. PubMed ID: 26845807 [TBL] [Abstract][Full Text] [Related]